Common Pain Points in the Pharma & GLP-1 Market The vast opportunities available in the GLP-1 space are undeniable
An early RCT in 44 patients with obesity and subclinical binge eating showed that liraglutide was better than diet and exercise alone in reducing binge-eating scores at 12 weeks 220 , but a later investigation of 27 adults with BED comparing liraglutide against placebo did not find any differences in the number of binging episodes over 17 weeks 218
With companies already pushing the limits of sustainable price increases, the focus must shift to operational efficiency powered by autonomous systems
Shipping Item Quality Customer Service Packaging I've been trying the GLP-1 Modulation Supplement for a week now, and although I'm still observing the long-term effects, the initial response is promising
doi:10.1023/a:1024132217870 271
While it might save money, stretching a pen past its intended duration may increase certain risks, a hidden price tag Ill uncover further down